Cover & TOC
Document type
monografie
monografie
Document record
Source: katalogy Medvik
Title
Emergency use designation of COVID-19 candidate vaccines : ethical considerations for current and future COVID-19 placebo-controlled vaccine trials and trial unblinding : policy brief : 18 December 2020
Author
Date of issue
2020
Publisher
©2020
[Geneva] : World Health Organization, 2020
Physical description
6 stran
Language
angličtina
Country
Švýcarsko
Document type
monografie
Link
Call number
NLK: online
Record number
MED00206101
Persistent link
Other Variant Titles
Ethical considerations for current and future COVID-19 placebo-controlled vaccine trials and trial unblinding policy brief : 18 December 2020
Abstract
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This policy brief was developed by the WHO Access to COVID-19 Tools (ACT) Accelerator Ethics & Governance Working Group, to provide guidance for researchers, sponsors, regulators, research ethics committees, and policy-makers, on these and related issues.
Internal Bibliographies/Indexes Note
Obsahuje bibliografické odkazy
Clipboard
Further actions